Sabari Surendran

Sabari Surendran, Pharm.D., RPh, currently serves as a Senior Principal Pharmacovigilance Scientist at Takeda, focusing on medical safety in gastrointestinal and inflammation areas since April 2023. Prior experience includes roles as Manager Safety Analysis Scientist and Pharmacovigilance Evaluation and Reporting Post-Doctoral Scientist Fellow at The Janssen Pharmaceutical Companies of Johnson & Johnson from April 2020 to April 2023. Sabari also completed various pharmacy externships and fellowships at organizations such as Johns Hopkins Bayview Medical Center, Johnson & Johnson, and AstraZeneca, gaining extensive experience in regulatory affairs, infectious disease medicine, and global patient safety. Education includes a Doctor of Pharmacy from Notre Dame of Maryland University and a Pre-Pharmacy Track from Wayne State University.